Leadership changes
Executive appointments and departures from SEC 8-K filings, updated within hours of each filing.
Updated Nov 6, 2026
Changes, November 2026
292
Appointments
143
Departures
34
Browse by role
Get new CFO appointments the day the filing lands.
Browse by month
Filters
3,420 changes
| Filing date | Company | Person | Role | Change | Effective date | Source |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | RALPH LAUREN CORP | Halide Alagoz | Chief Operating & Product OfficerCOO | Appointed | Nov 29, 2026 | SEC 8-K |
| Sep 3, 2026 | RALPH LAUREN CORP | Robert (Bob) Ranftl | Chief Operating OfficerCOO | Departed | n/a | SEC 8-K |
| Sep 3, 2026 | RESOURCES CONNECTION, INC. | Jennifer Y. Ryu | Executive Vice President and Chief Financial OfficerCFO | Departed | Oct 2, 2026 | SEC 8-K |
| Sep 3, 2026 | RESOURCES CONNECTION, INC. | Jessica Block | Interim Chief Financial OfficerCFO | Appointed | Oct 3, 2026 | SEC 8-K |
| Sep 3, 2026 | SCOTTS MIRACLE-GRO CO | Christopher J. Hagedorn | Executive Vice President & Chief Strategy OfficerExecutive Vice President & Chief Strategy Officer | Departed | Sep 30, 2026 | SEC 8-K |
| Sep 3, 2026 | UiPath, Inc. | Yazdi Bagli | directordirector | Appointed | Sep 3, 2026 | SEC 8-K |
| Sep 3, 2026 | UiPath, Inc. | Hitesh Ramani | Chief Financial OfficerCFO | Appointed | Sep 3, 2026 | SEC 8-K |
| Sep 3, 2026 | UiPath, Inc. | Ashim Gupta | Chief Financial OfficerCFO | Departed | Sep 3, 2026 | SEC 8-K |
| Sep 3, 2026 | UiPath, Inc. | Brad Brubaker | Chief Legal & Administrative OfficerCLO | Appointed | Sep 3, 2026 | SEC 8-K |
| Sep 3, 2026 | Vaxcyte, Inc. | David McAvoy | Chief Legal OfficerCLO | Appointed | Aug 31, 2026 | SEC 8-K |
| Sep 3, 2026 | WD 40 CO | Keith Stauffer | Vice President, Global FinanceVice President, Global Finance | Appointed | Sep 7, 2026 | SEC 8-K |
| Sep 3, 2026 | WD 40 CO | Keith Stauffer | Chief Financial OfficerCFO | Appointed | Nov 2, 2026 | SEC 8-K |
| Sep 3, 2026 | WD 40 CO | Sara K. Hyzer | Division President, AmericasPresident | Role change | Nov 2, 2026 | SEC 8-K |
| Sep 3, 2026 | WD 40 CO | Sara K. Hyzer | Chief Financial OfficerCFO | Departed | Nov 2, 2026 | SEC 8-K |
| Sep 2, 2026 | ACRO BIOMEDICAL CO., LTD. | Yu-Ting, Su | chief executive officerCEO | Departed | Sep 2, 2026 | SEC 8-K |
| Sep 2, 2026 | ACRO BIOMEDICAL CO., LTD. | Shao-Hsiang Shih | chairmanchairman | Appointed | Sep 2, 2026 | SEC 8-K |
| Sep 2, 2026 | ACRO BIOMEDICAL CO., LTD. | Jing-Zhou Chen | chief executive officerCEO | Appointed | Sep 2, 2026 | SEC 8-K |
| Sep 2, 2026 | Allogene Therapeutics, Inc. | Geoffrey Parker | Executive Vice President and Chief Financial Officer and principal financial officerCFO | Departed | Nov 6, 2026 | SEC 8-K |
| Sep 2, 2026 | American Healthcare REIT, Inc. | Aric Chang | Chief Financial OfficerCFO | Appointed | Oct 1, 2026 | SEC 8-K |
| Sep 2, 2026 | American Healthcare REIT, Inc. | Brian S. Peay | Chief Financial OfficerCFO | Departed | Sep 30, 2026 | SEC 8-K |
- RALPH LAUREN CORPAppointed
Halide Alagoz COO
Filed Sep 3, 2026Effective Nov 29, 2026SEC 8-K
- RALPH LAUREN CORPDeparted
Robert (Bob) Ranftl COO
Filed Sep 3, 2026SEC 8-K
- RESOURCES CONNECTION, INC.Departed
Jennifer Y. Ryu CFO
Filed Sep 3, 2026Effective Oct 2, 2026SEC 8-K
- RESOURCES CONNECTION, INC.Appointed
Jessica Block CFO
Filed Sep 3, 2026Effective Oct 3, 2026SEC 8-K
- SCOTTS MIRACLE-GRO CODeparted
Christopher J. Hagedorn Executive Vice President & Chief Strategy Officer
Filed Sep 3, 2026Effective Sep 30, 2026SEC 8-K
- UiPath, Inc.Appointed
Yazdi Bagli director
Filed Sep 3, 2026Effective Sep 3, 2026SEC 8-K
- UiPath, Inc.Appointed
Hitesh Ramani CFO
Filed Sep 3, 2026Effective Sep 3, 2026SEC 8-K
- UiPath, Inc.Departed
Ashim Gupta CFO
Filed Sep 3, 2026Effective Sep 3, 2026SEC 8-K
- UiPath, Inc.Appointed
Brad Brubaker CLO
Filed Sep 3, 2026Effective Sep 3, 2026SEC 8-K
- Vaxcyte, Inc.Appointed
David McAvoy CLO
Filed Sep 3, 2026Effective Aug 31, 2026SEC 8-K
- WD 40 COAppointed
Keith Stauffer Vice President, Global Finance
Filed Sep 3, 2026Effective Sep 7, 2026SEC 8-K
- WD 40 COAppointed
Keith Stauffer CFO
Filed Sep 3, 2026Effective Nov 2, 2026SEC 8-K
- WD 40 CORole change
Sara K. Hyzer President
Filed Sep 3, 2026Effective Nov 2, 2026SEC 8-K
- WD 40 CODeparted
Sara K. Hyzer CFO
Filed Sep 3, 2026Effective Nov 2, 2026SEC 8-K
- ACRO BIOMEDICAL CO., LTD.Departed
Yu-Ting, Su CEO
Filed Sep 2, 2026Effective Sep 2, 2026SEC 8-K
- ACRO BIOMEDICAL CO., LTD.Appointed
Shao-Hsiang Shih chairman
Filed Sep 2, 2026Effective Sep 2, 2026SEC 8-K
- ACRO BIOMEDICAL CO., LTD.Appointed
Jing-Zhou Chen CEO
Filed Sep 2, 2026Effective Sep 2, 2026SEC 8-K
- Allogene Therapeutics, Inc.Departed
Geoffrey Parker CFO
Filed Sep 2, 2026Effective Nov 6, 2026SEC 8-K
- American Healthcare REIT, Inc.Appointed
Aric Chang CFO
Filed Sep 2, 2026Effective Oct 1, 2026SEC 8-K
- American Healthcare REIT, Inc.Departed
Brian S. Peay CFO
Filed Sep 2, 2026Effective Sep 30, 2026SEC 8-K